<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36157568</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>Suppl 1</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Enhancing acute flaccid paralysis surveillance system towards polio eradication: reverse cold chain monitoring in Nigeria, 2017 to 2019.</ArticleTitle><Pagination><StartPage>7</StartPage><MedlinePgn>7</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.supp.2021.40.1.27534</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Highly sensitive acute flaccid paralysis (AFP) surveillance is critical for detection of poliovirus circulation and documentation for polio-free certification. The reverse cold chain (RCC) is a system designed to maintain stool specimens in appropriate temperature for effective detection of poliovirus in the laboratory. We monitored the RCC of AFP surveillance in Nigeria to determine its effectiveness in maintaining viability of enterovirus.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A descriptive cross-sectional study was conducted from November 2017 to December 2019. We included AFP cases from 151 Local Government Areas and monitored RCC of paired stool specimens from collection to arrival at laboratories. The national guideline recommends RCC temperature of +2 to +8°C and a non-polio enterovirus (NPENT) detection rate of ≥10%. We analyzed data with Epi Info 7, and presented results as frequencies and proportions, using Chi-square statistic to test for difference in enterovirus isolation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of the 1,042 tracked paired stool specimens, 1,038(99.6%) arrived at the laboratory within 72 hours of collection of second specimen, 824(79.1%) were maintained within recommended temperature range, and 271(26%) yielded enteroviruses: 200(73.8%) NPENT, 66(24.4%) Sabin, 3(1.1%) vaccine derived poliovirus type 2 and 2(0.7%) mixture of Sabin and NPENT. The NPENT and Sabin rates were 19.2% and 6.7% respectively. Twenty-five percent of 824 specimens maintained within recommended temperature range, compared with 29.8% of 218 specimens with temperature excursion yielded enteroviruses (P=0.175).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">the RCC of AFP surveillance system in the study area was optimal and effective in maintaining the viability of enteroviruses. It was unlikely that poliovirus transmission was missed during the intervention.</AbstractText><CopyrightInformation>©Samuel Luka Abbott et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abbott</LastName><ForeName>Samuel Luka</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>African Field Epidemiology Network, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamisu</LastName><ForeName>Abdullahi Walla</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>World Health Organization, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gidado</LastName><ForeName>Saheed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>African Field Epidemiology Network, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etapelong</LastName><ForeName>Sume Gerald</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>World Health Organization, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edukugho</LastName><ForeName>Aboyowa Arayuwa</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>African Field Epidemiology Network, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Isiaka Ayodeji</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>World Health Organization, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mawashi</LastName><ForeName>Kabir Yusuf</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>National Primary Health Care Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukbuk</LastName><ForeName>David Nadeba</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Polio Laboratory, University of Maiduguri, Borno State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baba</LastName><ForeName>Marycelin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Polio Laboratory, University of Maiduguri, Borno State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adekunle</LastName><ForeName>Adeniji Johnson</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Polio Laboratory, University College Hospital Ibadan, Oyo State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamu</LastName><ForeName>Usman Saidu</ForeName><Initials>US</Initials><AffiliationInfo><Affiliation>National Primary Health Care Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damisa</LastName><ForeName>Eunice</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Primary Health Care Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waziri</LastName><ForeName>Ndadilnasiya Endie</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>African Field Epidemiology Network, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Archer</LastName><ForeName>Wiedad Roodly</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>Centre for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franka</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiesen</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Disease Control and Prevention, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braka</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>World Health Organization, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolu</LastName><ForeName>Omotayo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centre for Disease Control and Prevention, Nigeria Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>World Health Organization, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shuaib</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Primary Health Care Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002292" MajorTopicYN="Y">Carcinoma, Renal Cell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020805" MajorTopicYN="N">Central Nervous System Viral Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007680" MajorTopicYN="Y">Kidney Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009187" MajorTopicYN="N">Myelitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="N">Neuromuscular Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012034" MajorTopicYN="N">Refrigeration</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AFP surveillance</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">reverse cold chain</Keyword><Keyword MajorTopicYN="N">temperature excursion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>26</Day><Hour>17</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36157568</ArticleId><ArticleId IdType="pmc">PMC9474949</ArticleId><ArticleId IdType="doi">10.11604/pamj.supp.2021.40.1.27534</ArticleId><ArticleId IdType="pii">PAMJ-SUPP-40-1-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greene SA. Progress Toward Polio Eradication-Worldwide, January 2017-March 2019. MMWR Morb Mortal Wkly Rep. 2019;68</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6532951</ArticleId><ArticleId IdType="pubmed">31120868</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan F. Progress Toward Polio Eradication-Worldwide, January 2016-March 2018. MMWR Morb Mortal Wkly Rep. 2018;67</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5944975</ArticleId><ArticleId IdType="pubmed">29746452</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH . World Health Organ Geneva Switz. 2015. Enterovirus surveillance guidelines: Guidelines for enterovirus surveillance in support of the Polio Eradication Initiative.</Citation></Reference><Reference><Citation>WHO-recommended standards for surveillance of selected vaccine preventable diseases. 2003.</Citation></Reference><Reference><Citation>World Health Organization Global Polio Surveillance Action Plan, 2018-2020 (WHO/POLIO/19.10) 2019 2018-2020.</Citation></Reference><Reference><Citation>GPEI Two Years Free From Wild Polio in Nigeria. Accessed on 29 September 2020.</Citation></Reference><Reference><Citation>WHO Polio Eradication Initiative Innovations in reverse cold-chain building resilience for disease surveillance in Sudan. Accessed on 25 September 2020.</Citation></Reference><Reference><Citation> 
 https://www.who.int/polio-transition/documents-resources/best-practices-active-surveillance
.</Citation></Reference><Reference><Citation>LogTag Recorders Cold Chain Science E. Accessed on 29 September 2020.</Citation></Reference><Reference><Citation>World Health Organization Guidelines for the Safe Transport of infectious Substances and Diagnostic Specimens. Accessed on 29 September 2020.</Citation></Reference><Reference><Citation>World Health Organization Polio laboratory manual. WHO Libr. 2004. Aug, p. 157.</Citation></Reference><Reference><Citation>Adu FD, Idowu AA, Akintokun AK, Adeniji JA, Ajuwon BO. Effect of Temperature and Distance on the Viral Outcome of Clinical Specimens From Acute Flaccid Paralysis Cases in Nigeria. J Clin Lab Anal. 2012;26(4):254–261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6807550</ArticleId><ArticleId IdType="pubmed">22811358</ArticleId></ArticleIdList></Reference><Reference><Citation>Odoom JK, Ntim NAA, Sarkodie B, Addo J, Minta-Asare K, Obodai E, et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009-20. BMC Public Health. 2014;14(1):1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4094438</ArticleId><ArticleId IdType="pubmed">24996415</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AT, Williams AJ, Gary HE, Pallansch MA, Wassilak SGF, Oberste MS. Effect of time at temperature on wild poliovirus titers in stool specimens. Virology. 2015;482:28–31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4620922</ArticleId><ArticleId IdType="pubmed">25817402</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassey BE, Fiona B, Muluh TJ, William K, Toritseju MS, Oyetunji A, et al. Distribution Pattern of the Non Polio Enterovirus (NPEV) Rate in Children with Acute Flaccid Paralysis Reported to the Surveillance System in Nigeria 2010-20. Health (NY) 2018;10(7):907–918.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>